BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
3/22/19 Sanofi (SNY) Zynquista for Diabetes Mellitus, Type I Subscribers Only Subscribers Only Subscribers Only
3/21/19 Biogen (BIIB) Aducanumab for Alzheimer's Disease (AD) Subscribers Only Subscribers Only Subscribers Only
3/21/19 Novartis (NVS) Emricasan for Non-Alcoholic Steatohepatitis (NASH) Subscribers Only Subscribers Only Subscribers Only
3/19/19 AbbVie (ABBV) Venclexta for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
3/19/19 Pfizer (PFE) Talzenna for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 03/23/19 Subscribers Only Subscribers Only Trial Data - Updated Results
03/23/19 Subscribers Only Subscribers Only Trial Data - Updated Results
03/23/19 Subscribers Only Subscribers Only Trial Data - Updated Results
03/23/19 Subscribers Only Subscribers Only Trial Data - Final Results
03/23/19 Subscribers Only Subscribers Only Trial Data - Other
Back to the top Back to the top